Head-to-head · WeighScore
Claya vs Willow
By GLP-1 ScorecardUpdated
Score comparison
Claya has the higher recorded score — 62.8/100 to 58.2/100.
Claya grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Claya | Willow |
|---|---|---|
| WeighScore | 62.8/100 | 58.2/100 |
| Grade | C | C |
| Site position | #298 | #342 |
| Semaglutide | $299/mo (compounded) | $299/mo (starting dose, compounded) |
| Tirzepatide | $299/mo (compounded) | $399/mo (starting dose, compounded) |
| Coverage | Coverage not published | Multi-state; confirm location and preparation |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #298 · C
Strengths
- Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
- Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
- Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
- Weight-loss money-back guarantee published on the homepage
- Free expedited shipping included in the monthly price
What to consider
- States-served list not disclosed — you must check at checkout
- LegitScript certification status not displayed
- Corporate legal entity not disclosed on the site or privacy policy
- Oral compounded tablets have weaker efficacy data than injectable semaglutide
- Intro pricing is higher at refill ($299), erasing the first-month advantage
Site position #342 · C
Strengths
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
What to consider
- Dose and refill changes may change the bill
- Confirm the assigned pharmacy and cancellation before processing
Featured provider
Willow
Willow scores 58.2/100 (C). Telehealth provider offering compounded GLP-1 medications in both tablet and injectable formats.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.